HIPERKALSEMIA ADALAH PDF

;46(2) 17] Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran. ;46(2)–17] Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran. ;46(2)–17]. Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration. Hiperkalsemia pada Keganasan: Karakteristik.

Author: Kazralmaran Moogurisar
Country: Portugal
Language: English (Spanish)
Genre: Education
Published (Last): 4 April 2018
Pages: 247
PDF File Size: 2.66 Mb
ePub File Size: 11.28 Mb
ISBN: 838-7-88890-902-9
Downloads: 10543
Price: Free* [*Free Regsitration Required]
Uploader: Taumi

The aim of this study was to determine the clinical characteristics and treatment outcome in hypercalcemia of malignancy.

There were 40 patients with hypercalcemia of malignancy, consisted of 22 hematologic malignancies and 18 solid tumors. How do loop diuretics cause hypokalemia? The ion calcium level in subjects received Systemic therapy for bone metastases. Clinical Characteristics and Treatment Outcome.

Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran Terapi

This reference summary will help More information. CASE 23 A year-old man with a history of heart disease is admitted to the hospital with congestive heart failure. Acid-Base Balance and the Anion Gap 1. There was no cardiac arrest in all our subjects. The kidneys make urine as well as determining how concentrate or aadalah the urine. Betsi Cadwaladr University Health Version: The difference in the changes of ion calcium between subjects treated with biophosphonate and hiperkwlsemia who did not receive bisphosphonate was calculated by Mann Whitney test.

Hasan Hiper,alsemia Hospital Bandung during the period of December March Inclusion criteria were age above 14 years old, had hematologic malignancy or solid tumor confirmed through histopathologic analysis.

This study results could be used in 8, 4 and 4 subjects, respectively. Medical Necessity Criteria Subject: Intracellular Fluid ICF 2. In conclusion, the malignancy causing The nitrogen-containing bisphosphonates, which hypercalcemia was about the same proportion are second or third generation bisphosphonates between hematologic and solid tumor.

  DBMS ELMASRI NAVATHE PDF

Berenson G, Hirschberg R.

WikiPage – eAnswers

All subjects had decreased ion calcium level after treatment. What is the effect of aldosterone on sodium and potassium? A group of diseases characterized More information. Dari 40 penderita dengan hiperkalsemia pada keganasan, didapatkan 22 keganasan hematologi dan 18 tumor padat.

Iran J Kidney Dis. To make this website work, we log user data and share it with processors. Calcium serum, plasma, blood Calcium serum, plasma, blood 1 Name and description of analyte 1.

N Engl J Med. Among solid tumor, the most frequent one was breast cancer followed by lung cancer and head and neck cancer.

This reference summary will help. CA Cancer J Clin. In 16 subjects, no symptoms were found.

All subjects received rehydration with normal saline. The aim of this study was to determine the clinical characteristics and treatment outcome in hypercalcemia of malignancy. Among the hematologic malignancy, malignant lymphoma was found in fifteen subjects, followed by seven subjects with Table 2 Clinical Manifestation of Hypercalcemia Clinical Manifestations n No symptom 16 Disturbance of 4 consiousness Dehydration 18 Constipation 6 Nausea and vomiting 6 myeloma multiple.

Now, they are focused on it. His pulmonary edema and peripheral More information. Treatment of oncologic emergencies. In conclusion, hematologic and solid tumors are found in about the same proportion in hypercalcemia associated malignancy. Berenson G, Hirschberg R. Parathyroid hormone serum, plasma Parathyroid hormone serum, plasma 1 Name and description of analyte 1.

Treatment either with bisphosphonate or normal saline rehydration alone gave good result.

  DYNACAST PRELUDE PDF

Bisphosphonate was given in 26 subjects. Simpulan, proporsi keganasan penyebab hiperkalsemia hampir sama antara keganasan hematologi dan tumor padat. Now concerning the parathyroid gland. We had calcium ion level data before treatment algorithm.

Adala CAS registry number. Bisfosfonat, hiperkalsemia pada keganasan, rehidrasi Correspondence: Why healthy bones matter The healthier your bones The more active you can be Bone health has a major effect on your quality of life More information.

Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran Terapi – PDF

Jpn J Clin Oncol. Pada 16 subjek tidak ditemukan gejala. There were 40 patients with hypercalcemia of malignancy, consisted of 22 hematologic malignancies and 18 solid tumors. Clinical Characteristic and Treatment Outcome hypercalcemia and osteolytic bone disease. Patients with acute or chronic renal failure, granulomatous disorders, adrenal insuffuciency, and thyrotoxicosis as well as those with thiazides consumption were not eligible for this study. School of Medicine Nephrology clinical undergraduate training: Bisphosphonate compounds can be divided into two distinct pharmacological classes with different mechanisms of action depending on whether they contain a nitrogen atom in their side chains of non-nitrogen-containing bisphosphonates, which are the first generation bisphosphonates, that include etidronate and clodronate, are metabolized intracellularly to cytotoxic, non-hydrolyzable analogs of adenosine triphosphate ATP that may inhibit ATPdependent intracellular enzymes in osteoclasts.

Curr Opin subjects who did not received bisphosphonate Endocrinol Diabetes Obes.